Delivery Order SPM20005D3301-RG19
- Not listed
- This federal contract award, valued at $82,640.38, was made by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for the provision of pharmaceutical and medical supplies under the TRICARE West program. The contract is a firm fixed-price delivery order, with no set-aside designation. Cardinal Health, a large for-profit organization, has a long-standing relationship with the federal government, particularly the Department of Defense (DoD), Department of Veterans Affairs (VA), and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $91,033.20, is a firm fixed-price delivery order for the supply of pharmaceutical products and medical consumables to the TRICARE West program. Cardinal Health, the prime contractor, has a long-standing relationship with the U.S. government, providing distribution services for various federal agencies, including the...
- The federal contract award is for the provision of pharmaceutical and medical supplies to the U.S. government's Defense Logistics Agency (DLA) under the TRICARE West program. The prime contractor is Cardinal Health, Inc., a global healthcare services and products company. The contract is a delivery order valued at $116,296.21 with a firm fixed-price pricing type. There is no set-aside designation for this award. Cardinal Health has a long-standing relationship with government procurement,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company. The $92,320.80 firm fixed-price delivery order is for the provision of pharmaceutical products, including medications and medical consumables, to support the TRICARE West program. Cardinal Health has a long history of providing pharmaceutical distribution services to various government agencies, including the Department of Defense,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, for the provision of pharmaceutical distribution services under the TRICARE West program. The single-award, firm fixed-price delivery order, valued at $147,969.02, does not have a set-aside designation, reflecting Cardinal Health's status as a large, for-profit organization. The contract is part of the DLA's Pharmaceutical Prime Vendor program,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $77,347.73 firm fixed-price delivery order contract is for the supply of various pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to support the TRICARE WEST program. Cardinal Health is a long-standing federal contractor, with a focus on providing pharmaceutical distribution services to...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The $107,907.27 firm fixed-price delivery order is for the supply of a variety of pharmaceutical products, including antibiotics, pain medications, vaccines, and specialty drugs, to support the TRICARE West program. Cardinal Health has a long-standing relationship with the Department of Defense (DoD),...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at $192,768.80, is for the provision of pharmaceutical products and medical supplies to support the TRICARE West program, which provides healthcare services to U.S. military personnel, retirees, and their families. Cardinal Health has a long-standing relationship with the U.S. federal government, serving...
- The federal contract award is for the supply of pharmaceutical and medical products to the U.S. government. The prime contractor is Cardinal Health, Inc., a global healthcare services and products company with extensive experience in government contracting. This $89,107.76 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain program on May 7, 2015, with a completion date of May 8, 2015. The contract is for the TRICARE West program...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major pharmaceutical and medical supply distributor. The $115,940.37 firm fixed-price contract is for the provision of TRICARE West medical supplies, including prescription medications, vaccines, and other consumables. Cardinal Health has a long history of providing pharmaceutical distribution services to the U.S. Department of Defense, Department of Veterans Affairs, and National...
- SPM20005D3301Indefinite Delivery Contract
- SPM20005D3301-RG19Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for the provision of pharmaceutical and medical supply distribution services under the TRICARE West program. The contract, valued at $177,079.43, is a firm fixed-price delivery order with no set-aside designation. Cardinal Health, a large for-profit healthcare services and products company, has a long-standing relationship with the federal government, particularly the Department of Defense (DoD), Department of Veterans Affairs (VA), and National Institutes of Health (NIH), providing a wide range of pharmaceutical and medical products, including prescription medications, vaccines, and radiopharmaceuticals. This contract is part of the DLA's Pharmaceutical Prime Vendor program, which supplies medical products to military treatment facilities and deployed troops worldwide. Cardinal Health also holds a separate indefinite delivery contract (IDC) with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets, valued at $10,056,938.10, further demonstrating the company's capabilities in managing large-scale pharmaceutical supply agreements across multiple government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $177.1k | 5/13/15 |